Trulieve Cannabis Corp.

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp. (CSE:TRUL) said it has purchased 57,000 of its $1,000 face value senior secured notes due October 6, 2026, for a purchase price of US$46.7 million, representing a 16.5% discount to par, plus accrued interest. The notes represent 8% of its Senior Secured Notes due in 2026, Trulieve said Thursday.

Trulieve Cannabis repurchases $47.6M in debt at a discount

Company celebrates grand opening and expands access to low-THC products  for patients in the Augusta metropolitan area TALLAHASSEE, Fla. , Sept. 22, 2023 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, announced the grand opening of a new medical cannabis dispensary located at 4218 Washington Road in Evans, GA.

Trulieve Opening Medical Cannabis Dispensary in Evans, Georgia

TALLAHASSEE, Fla. , Sept. 21, 2023 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the open market purchase of 57,000 of its USD $1,000 face value senior secured notes due October 6, 2026 (the "Notes") for a purchase price of USD $47.6 million, which represents a 16.5% discount to par, plus accrued interest.

Trulieve Announces Purchase of 8% Senior Secured Notes due 2026

Green Thumb Industries Inc.

Jesse Redmond discusses the current state of the cannabis industry and the opportunities it presents for investors. He emphasizes the importance of focusing on quality companies and having a long-term investment horizon.

Is It Really Time To Be Bullish On Cannabis Stocks?

As we enter this week in September 2023, the cannabis industry is again in the spotlight, with marijuana stocks rising. As the marijuana industry gains traction, investors and traders alike are keeping an eye on the best marijuana stocks to watch this week. With recent changes in cannabis regulation and public perception, the market has intriguing prospects. Still, it's critical to approach it with a strategic perspective and correct risk management tactics to navigate the inherent volatility.

Green Gains: Top Marijuana Stocks for September 2023

Curaleaf Holdings, Inc.

Is it 2018 all over again? For investors asking: “Why are cannabis stocks up today?

Why Are Cannabis Stocks Up Today?

Aurora Cannabis

Canopy Growth

Tilray Brands

Cannabis multi-state operator (MSO) stocks are set to end another week on a high on renewed optimism around marijuana banking reform. The Senate Banking Committee is expected to hold a markup session for the Secure and Fair Enforcement (SAFE) Banking Act in the week starting September 25, according to sources with knowledge of the matter.

Cannabis MSO shares rise with marijuana banking reform poised to win Senate Committee's approval

Company celebrates grand opening and expands medical cannabis access to patients in Escambia and Santa Rosa counties TALLAHASSEE, Fla., Sept. 14, 2023 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced the opening of a new medical dispensary located at 5037 Hwy 90, Pace, Fla.

Trulieve Opening Medical Cannabis Dispensary in Pace, Florida

NewLake Capital Partners, Inc.

Alan Brochstein And Julian Lin discuss the importance of navigating timelines and federal legalization headlines in cannabis investing. Preferring REITs and Canadian LPs over US operators due to factors such as debt concerns and valuation.

Unlocking Cannabis: Legalization Timelines, Debt Risk + Unique Value Plays With Alan Brochstein And Julian Lin

Marijuana stocks have seen several days of better trading this past week. There were a few days when the cannabis sector was showing better momentum. This led to a recovery for certain marijuana stocks. Anytime there is a recovery in trading it gives hope towards future investing. No one wants to invest in a dying sector or one with no action. With cannabis being a new industry compared to others it is always a good sign to investors when there is a rise in trading.

Are These Marijuana Stocks Worth Buying Or Selling?

Leading cannabis multi-state operator recognized for innovative, best in class human capital management ("HCM") strategy via implementation of its TruU-GROW Employee Training Program TALLAHASSEE, Fla. , Sept. 12, 2023 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced its TruU-GROW cultivation training program has received six Gold awards for excellence in the 2023 Brandon Hall Group HCM Excellence Awards™.

Trulieve Employee Training Program Earns Multiple Gold Awards for Excellence

It's been an excellent month for cannabis stocks and it's not hard to see why. All evidence points to the fact that the federal government is considering rescheduling the recreational drug from Schedule I to Schedule III.

Fed Plans to Reschedule Marijuana Will Mostly Benefit These 3 Cannabis Stocks

TALLAHASSEE, Fla. , Sept. 7, 2023 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced planned event participation in September.

Trulieve Announces September 2023 Event Participation

Marijuana stocks could be the investment you need to make. To begin the cannabis industry is still young. Often times in an emerging industry there are a fair amount of obstacles to overcome. But there are also moments where investment opportunities take place. The cannabis sector is one that has a large amount of volatility. What this means is that a company can either trade up or down without warning. But for most marijuana stocks there has been a downtrend due to the amount of volatile behavior.

3 Marijuana Stocks For Cannabis Investing September 2023

Cronos Group

OrganiGram Holdings Inc.

Cannabis stocks continued to move higher following the Labor Day long weekend after the U.S. Department of Health and Human Services (HHS) last week recommended reclassifying marijuana as a lower-risk drug.

Cannabis stock rally continues on marijuana rescheduling hopes

2 Marijuana Stocks To Watch In September 2023

Cannabis stocks are on track to finish the week higher boosted by the news that the U.S. Department of Health and Human Services (HHS) has recommended reclassifying marijuana as a lower-risk drug.

Cannabis stocks set to end week on a high following marijuana rescheduling recommendation

Trulieve Cannabis stock soared 62% following the potential rescheduling of cannabis from a Schedule 1 controlled substance to a Schedule 3 drug. If cannabis is reclassified, Trulieve and other MSOs could potentially drop the 280E taxes and uplist to U.S. stock exchanges. Trulieve Cannabis could see a surge in free cash flow levels, greatly enhancing its capital position.

Trulieve Cannabis: Government May Finally Come To The Rescue

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Global X Cannabis ETF

The move by the Drug Enforcement Administration to review the Schedule I classification for cannabis sparked a wave of speculation and mostly positive comments from Wall Street on Thursday, but many questions remain.

HHS recommendation to reschedule cannabis keeps pot stocks hot, but questions remain

The US government is reconsidering how it classifies marijuana and cannabis companies are in party mode. According to reports, the Department of Health and Human Services (HHS) has recommended reclassifying marijuana as a lower-risk Schedule III drug, from Schedule I, easing restrictions on businesses operating in the sector.

Cannabis stocks on fire as US health department calls for easing restrictions

The U.S. Department of Health and Human Services is recommending to the U.S. Drug Enforcement Administration that cannabis should be reclassified as a Schedule III controlled substance under U.S. law from Schedule I now, according to a report by Bloomberg. Cannabis stocks are rallying, with the AdviserShares Pure US Cannabis ETF MSOS, +18.76% up by nearly 33%, and the ETFMG Alternative Harvest ETF MJ, +10.27% up by 19.5%.

U.S. Dept. of Health and Human Services recommends re-scheduling cannabis, as stocks in the sector rally

As the cannabis sector in the United States continues to expand, three notable marijuana stocks have emerged, with potential gains this week. The US cannabis industry seems promising, with a compound annual growth rate of 18.1% from 2021 to 2028. Curaleaf Holdings provides erratic but potentially profitable choices for short-term traders. Long-term investors, on the other hand, may find value in creative companies like Green Thumb Industries and their planned expansion plans.

High-Potential US Marijuana Stocks for Your Radar Ahead of September 2023

High Tide

Jazz Pharmaceuticals

SNDL Inc.

I will attempt to assess and rank the relative growth potential of the separate competitors in the industry. The industry faces multiple catalysts and is trading near 52-week lows. The cannabis ETFs are full of cash burning companies, so I am forced to research my own basket of stocks.

Finding The Long-Term Winners In The Cannabis Sector, August 2023 Update

Kinross Gold

Polestar Automotive Holding UK PLC

The massive euphoria in penny stocks has not repeated since 2021. The reason is tight monetary policies that have dampened overall market sentiments.

Penny Stock Goldmines: 3 Gems to Grab for Massive Gains by 2024

In Q3 2023, US marijuana stocks emerged as important stock market players, reflecting the fast-growing cannabis sector. The US cannabis sector has attracted attention for its profitable potential, with an astounding annual growth rate of 30% in 2023. In general, the future of the cannabis sector in the United States remains bright, thanks to rising legalization and altering societal attitudes.

News for Trulieve Cannabis Corp. Stock (TCNNF)